Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects > or =13 years of age. (Q54527329)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects > or =13 years of age (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Luigi R. Biasio

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

17

Jerald Sadoff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Clemente Diaz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Rocio Gonzalez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Rafael G Mendez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Sandro Cinquetti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Julie L Barben

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Anna Harmon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Ira Chalikonda

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Jeffrey G Smith

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Jon E Stek

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Andrew Robertson

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Michael J Caulfield

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Jeffrey L Silber

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Christina Y Chan

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Rupert Vessey

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Ivan S F Chan

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Holly Matthews

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

William Wang

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Katia Schlienger

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Florian P Schödel

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Protocol 049 Study Group

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

English

0 references

publication date

7 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

47-48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

6875-6885

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

Varicella mortality: trends before vaccine licensure in the United States, 1970-1994

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Seroepidemiology of varicella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

The seroepidemiology of varicella in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

The age of infection with varicella-zoster virus in St Lucia, West Indies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Costs And Benefits Of Routine Varicella Vaccination In German Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

A cost benefit analysis of routine varicella vaccination in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Italian Sentinel Group on Pediatric Infectious Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Postmarketing evaluation of the safety and effectiveness of varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Postlicensure safety surveillance for varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Effectiveness of live varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Ten year follow-up of healthy children who received one or two injections of varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Decline in mortality due to varicella after implementation of varicella vaccination in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Persistence of immunity to live attenuated varicella vaccine in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX? in healthy children*1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Antibody assays suitable for assessing immune responses to live varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Comparative analysis of two rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Varicella vaccination--a critical review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Varicella: a vaccine preventable disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Immunization of healthy adults with live attenuated varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.030

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.06.030

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17050042%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference